C-A4-03: Risks to the Newborn Associated with In-Utero Exposure to Beta-Blockers and Calcium-Channel Blockers

s 0.83, 1.1).For the remaining alert categories significantly higher proportions of final drug orders were appropriate in the intervention units: relative risk 2.4 for maximum frequency (1.4,4.4); 2.6 for drugs that should be avoided (1.4,5.0); and 1.8 for alerts to acquire missing information (1.1, 3.4).Overall, final drug orders were appropriate significantly more often than a relative risk 1.2 (1.0, 1.4).By tracking personnel time and expenditures, we estimated the cost of developing the CDSS as $48,668.57.Drug costs saved during the 12 months of the trial are estimated at $2,137.Conclusion: Clinical decision support for physicians prescribing medications for longterm care residents with renal insufficiency can improve the quality of prescribing decisions.However, patient well-being and quality of care rather than the business case related to cost savings are likely to be the key drivers for adoption of this HIT application.